Literature DB >> 25646039

CFTR Gene Mutations and Asthma in Indian Children: A Case-Control Study.

Pratibha Dixit1, Shally Awasthi1, Nutan Maurya1, Sarita Agarwal2, M Srinivasan2.   

Abstract

Cystic Fibrosis Trans membrane conductance regulator (CFTR) gene is an asthma susceptibility gene. In the present study we investigated the possible association of CFTR gene mutations in Indian asthmatic children as compared to controls. The study included 250 asthmatics and 250 age and sex matched controls. Case to control ratio for sample size was 1:1. Genotyping was performed for 24 CFTR gene mutations by ARMS-PCR and PCR-RFLP method. Among 24 CFTR gene mutations, heterozygous allele of R553X mutation was found in 4 (1.6 %) asthmatic cases and 2 (0.8 %) controls. Value of FVC and FEV1/FVC ratio were significantly lower in heterozygous individuals (p value <0.05). No significant difference was observed in the genotype and allele frequency of R553X mutation (OR = 1.339, 95 % CI = 0.755-2.374, p value = 0.685). Furthermore, all wild type homozygous alleles were observed in remaining 23 CFTR gene mutations. Our data concludes that R553X mutation was not significantly associated in Indian asthmatic children.

Entities:  

Keywords:  Asthma; CFTR gene; Mutations; North India

Year:  2013        PMID: 25646039      PMCID: PMC4310842          DOI: 10.1007/s12291-013-0400-6

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  45 in total

1.  CFTR and asthma in the French EGEA study.

Authors:  R de Cid; J C Chomel; C Lazaro; J Sunyer; M Baudis; T Casals; N Le Moual; A Kitzis; J Feingold; J Anto; X Estivill; F Kauffmann
Journal:  Eur J Hum Genet       Date:  2001-01       Impact factor: 4.246

Review 2.  The pathophysiology of asthma.

Authors:  Lee Maddox; David A Schwartz
Journal:  Annu Rev Med       Date:  2002       Impact factor: 13.739

3.  A pilot survey of cystic fibrosis clinical manifestations in CFTR mutation heterozygotes.

Authors:  C Castellani; C Quinzii; S Altieri; G Mastella; B M Assael
Journal:  Genet Test       Date:  2001

4.  [Carriers of cystic fibrosis are more susceptible to asthma. The Osterbro study].

Authors:  M Dahl; A T Hansen; P Lange; B G Nordestgaard
Journal:  Ugeskr Laeger       Date:  1999-08-09

5.  Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in Asians with chronic pulmonary disease: a pilot study.

Authors:  Nicola S P Ngiam; Samuel S Chong; Lynette P C Shek; Denise L M Goh; K C Ong; S Y Chng; G H Yeo; Daniel Y T Goh
Journal:  J Cyst Fibros       Date:  2006-03-06       Impact factor: 5.482

6.  Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis.

Authors:  J A Cohn; K J Friedman; P G Noone; M R Knowles; L M Silverman; P S Jowell
Journal:  N Engl J Med       Date:  1998-09-03       Impact factor: 91.245

7.  DeltaF508 heterozygosity in cystic fibrosis and susceptibility to asthma.

Authors:  M Dahl; A Tybjaerg-Hansen; P Lange; B G Nordestgaard
Journal:  Lancet       Date:  1998-06-27       Impact factor: 79.321

8.  Protection against bronchial asthma by CFTR delta F508 mutation: a heterozygote advantage in cystic fibrosis.

Authors:  S A Schroeder; D M Gaughan; M Swift
Journal:  Nat Med       Date:  1995-07       Impact factor: 53.440

Review 9.  Control of CFTR channel gating by phosphorylation and nucleotide hydrolysis.

Authors:  D C Gadsby; A C Nairn
Journal:  Physiol Rev       Date:  1999-01       Impact factor: 37.312

10.  The soluble tumor necrosis factor-alpha receptor suppresses airway inflammation in a murine model of acute asthma.

Authors:  Hae-Seong Nam; Sook Young Lee; Seung Jun Kim; Ju Sang Kim; Soon Seog Kwon; Young Kyoon Kim; Kwan Hyung Kim; Hwa Sik Moon; Jeong Sup Song; Sung Hak Park; Seok Chan Kim
Journal:  Yonsei Med J       Date:  2009-08-19       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.